Darunavir, Ritonavir

Darunavir and Ritonavir is a combination medication used in the treatment of HIV-1 infection. Darunavir, a protease inhibitor, works by inhibiting the enzyme responsible for the maturation of the virus, thereby preventing the production of new HIV particles. Ritonavir, a booster agent, enhances the effectiveness of Darunavir by increasing its concentration in the body.
This combination medication is typically used as part of a highly active antiretroviral therapy (HAART) regimen, which involves the simultaneous use of multiple drugs to maximize the suppression of HIV replication. HAART has been proven to significantly improve the quality of life and life expectancy of individuals living with HIV, reducing the risk of disease progression and opportunistic infections.
The precise dosage and duration of treatment will depend on the individual patient’s condition, response to therapy, and other medications they may be taking. Follow the prescribed dosing schedule and maintain regular appointments with healthcare professionals to monitor the effectiveness of the treatment and ensure patient safety.